Publication | Open Access

Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies

Breast OncologyMedicineBreast CancerCancer TreatmentHer2-targeted TherapiesRadiation OncologyCancer BiologyCell BiologyTumor BiologyEndocrine-related Cancer